{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:55Z","timestamp":1792784275054,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301823"],"award-info":[{"award-number":["82301823"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373928"],"award-info":[{"award-number":["82373928"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042025kf0062"],"award-info":[{"award-number":["2042025kf0062"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2815900"],"award-info":[{"award-number":["2024YFC2815900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.molmed.2026.08.004","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:08:05Z","timestamp":1789477685000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pulsatile farnesoid X receptor activation rewires liver disease pharmacology"],"prefix":"10.1016","author":[{"given":"Guangyuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6854-6040","authenticated-orcid":false,"given":"Pengfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2026.08.004_bb0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","article-title":"AI-powered therapeutic target discovery","volume":"44","author":"Pun","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.molmed.2026.08.004_bb0010","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001539","article-title":"Bile acid signaling in MASLD: from pathogenesis to therapeutic applications","author":"Simbrunner","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2026.08.004_bb0015","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41401-025-01726-0","article-title":"Epigenetic regulation and posttranslational modifications of FXR: underlying mechanisms and implications in digestive diseases","volume":"47","author":"Mi","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.molmed.2026.08.004_bb0020","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1038\/s41401-024-01329-1","article-title":"FXR activation remodels hepatic and intestinal transcriptional landscapes in metabolic dysfunction-associated steatohepatitis","volume":"45","author":"Wen","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.molmed.2026.08.004_bb0025","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1016\/j.cell.2024.10.001","article-title":"Structure-guided discovery of bile acid derivatives for treating liver diseases without causing itch","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2026.08.004_bb0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2024.09.008","article-title":"Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress","volume":"37","author":"Song","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2026.08.004_bb0035","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41586-026-10633-1","article-title":"A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases","volume":"655","author":"Zang","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.08.004_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41576-026-00962-2","article-title":"Time matters: circadian genetics and the molecular logic of human health and disease","author":"Kuo","year":"2026","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2026.08.004_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/science.adt0548","article-title":"Osteoarthritis treatment via the GLP-1-mediated gut-joint axis targets intestinal FXR signaling","volume":"388","author":"Yang","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.08.004_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s44386-025-00029-y","article-title":"Integrating artificial intelligence into small molecule development for precision cancer immunomodulation therapy","volume":"2","author":"Sutanto","year":"2025","journal-title":"NPJ Drug Discov."},{"key":"10.1016\/j.molmed.2026.08.004_bb0055","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41575-024-00913-4","article-title":"Cell senescence in liver diseases: pathological mechanism and theranostic opportunity","volume":"21","author":"Sanfeliu-redondo","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426002145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426002145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:22:39Z","timestamp":1789849359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491426002145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":11,"alternative-id":["S1471491426002145"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2026.08.004","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulsatile farnesoid X receptor activation rewires liver disease pharmacology","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2026.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}